Home › Funds › DAFNA Capital Management LLC › BCAX

DAFNA Capital Management LLC position in BCAX

BICARA THERAPEUTICS INC · Health Care

DAFNA Capital Management LLC reported holding 284,955 shares of BCAX (BICARA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$8.5M, representing 1.61% of its reported portfolio and ranking #17 among its reported holdings. DAFNA Capital Management LLC has disclosed BCAX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)284.95K sh
Reported value held$8.46M
Portfolio Weight1.61%
First reportedQ4 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How DAFNA Capital Management LLC's BCAX position evolved

DAFNA Capital Management LLC first disclosed a stake in BCAX in Q4 2024 at 105,500 shares (US$1.8M). The position peaked in Q2 2026 at 284,955 shares, worth US$8.5M. Across 7 filings, DAFNA Capital Management LLC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 284,955 shares valued at US$8.5M — a reduction of -136,778 shares quarter over quarter.. Notable position changes include a 101% increase in Q1 2025 (shares fell 29% over the following quarter), a 50% increase in Q2 2025 (shares rose 70% over the following quarter), a 61% increase in Q1 2026 (shares rose 49% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 105.50K $1.84M New
Q1 2025 212.00K $2.76M Add
Q2 2025 317.00K $2.94M Add
Q3 2025 317.00K $5.01M Hold
Q4 2025 261.58K $4.40M Reduce
Q1 2026 421.73K $8.39M Add
Q2 2026 284.95K $8.46M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BCAX and 13F data

BCAX (BICARA THERAPEUTICS INC) is a Health Care company. 58 other funds we track also report a position in BCAX — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$215.4M), Siren, L.L.C. (US$166.4M), Vestal Point Capital, LP (US$155.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BCAX

All BCAX fund holders →

FAQ

How long has DAFNA Capital Management LLC held BCAX?

DAFNA Capital Management LLC has disclosed BCAX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is DAFNA Capital Management LLC's current position in BCAX?

As of Q2 2026, DAFNA Capital Management LLC holds 284.95K shares of BCAX (BICARA THERAPEUTICS INC), valued at $8.46M, representing 1.61% of its reported portfolio and ranking #17.

Has DAFNA Capital Management LLC been buying or selling BCAX?

In the latest 13F filing (Q2 2026), DAFNA Capital Management LLC reduced its position in BCAX. The position peaked in Q2 2026 at 284.95K shares.

Which other funds hold BCAX?

Other major institutional holders of BCAX include RA CAPITAL MANAGEMENT, L.P., Siren, L.L.C., Vestal Point Capital, LP, among 58 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.